Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL - Get Free Report) has received an average rating of "Moderate Buy" from the seventeen analysts that are covering the company, Marketbeat Ratings reports. One research analyst has rated the stock with a sell recommendation, two have given a hold recommenda